Dysregulated TRIM expression or activity contributes to the pathogenesis of autoimmune diseases, including SLE, Sjögren's syndrome, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and type I diabetes. The gene discussed is TRAT1; the disease is systemic lupus erythematosus.